Values as of: 2024-11-05
ETF | Health |
Last Closing
USD 91.35Change
+1.47 (+1.64)%Market Cap
USD 0.21BVolume
6.17KAnalyst Target
N/AVerdict
Verdict
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).
Company Website : http://www.spdrs.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. |
+1.08 (+0.74%) |
USD 40.26B |
| FHLC | Fidelity® MSCI Health Care In.. |
+0.58 (+0.83%) |
USD 2.86B |
| FXH | First Trust Health Care AlphaD.. |
+1.32 (+1.22%) |
USD 1.19B |
| IDNA | iShares Genomics Immunology an.. |
+0.18 (+0.71%) |
USD 0.14B |
| SBIO | ALPS Medical Breakthroughs ETF |
+0.83 (+2.15%) |
USD 0.12B |
| XHS | SPDR® S&P Health Care Service.. |
+0.94 (+1.00%) |
USD 0.08B |
| HTEC | Robo Global® Healthcare Techn.. |
+0.32 (+1.10%) |
USD 0.05B |
| BBP | Virtus LifeSci Biotech Product.. |
+0.78 (+1.21%) |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. |
+0.30 (+1.03%) |
USD 0.01B |
| IHE | iShares U.S. Pharmaceuticals E.. |
+0.41 (+0.60%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| INAV | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -45.79% | 38% | F | 11% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -45.79% | 38% | F | 12% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -35.42% | 43% | F | 12% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -35.42% | 43% | F | 13% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -43.65% | 29% | F | 17% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -43.65% | 29% | F | 18% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 0.60% | 29% | F | 37% | F | ||
| Dividend Return | 0.60% | 29% | F | 26% | F | ||
| Total Return | 0.01% | 5% | F | 1% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 26.63% | 33% | F | 40% | F | ||
| Risk Adjusted Return | 2.27% | 29% | F | 24% | F | ||
| Market Capitalization | 0.21B | 70% | C- | 37% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
